Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2007The Journal of Gene Medicine

Intravenous glial‐derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter

View Full Paper
Ask AI
Bookmark
Share

Authors

CXChun‐Fang XiaChinese PLA General HospitalRBRubén J. BoadoUniversity of California, Los AngelesYZYun ZhangBengbu Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xia et al. (2007) studied this question.

synapsesocial.com/papers/6a6375583eb69703d1b7184dhttps://doi.org/10.1002/jgm.1152
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomes2007 · 24 citations
  2. 2Organ‐specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice2004 · 29 citations
  3. 3Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter2004 · 134 citations
  4. 4Intravenous Nonviral Gene Therapy Causes Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism2003 · 196 citations
  5. 5Global non-viral gene transfer to the primate brain following intravenous administration2003 · 179 citations